These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2831258)

  • 1. Intact cell and cell-free phosphorylation and concomitant activation of a low Km, cAMP phosphodiesterase found in human platelets.
    Macphee CH; Reifsnyder DH; Moore TA; Beavo JA
    J Cyclic Nucleotide Protein Phosphor Res; 1986-1987; 11(7):487-96. PubMed ID: 2831258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of cyclic GMP-binding and cyclic AMP-specific phosphodiesterases of rat platelets by a mechanism involving cyclic AMP-dependent phosphorylation.
    Tremblay J; Lachance B; Hamet P
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(4):397-411. PubMed ID: 2411769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylation results in activation of a cAMP phosphodiesterase in human platelets.
    Macphee CH; Reifsnyder DH; Moore TA; Lerea KM; Beavo JA
    J Biol Chem; 1988 Jul; 263(21):10353-8. PubMed ID: 2839485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
    Harrison SA; Reifsnyder DH; Gallis B; Cadd GG; Beavo JA
    Mol Pharmacol; 1986 May; 29(5):506-14. PubMed ID: 3010079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytosolic and sarcoplasmic reticulum-associated low Km, cGMP-inhibited cAMP phosphodiesterase in mammalian myocardium.
    Smith CJ; Krall J; Manganiello VC; Movsesian MA
    Biochem Biophys Res Commun; 1993 Jan; 190(2):516-21. PubMed ID: 8381278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stimulation by insulin of a serine kinase in human platelets that phosphorylates and activates the cGMP-inhibited cAMP phosphodiesterase.
    López-Aparicio P; Belfrage P; Manganiello VC; Kono T; Degerman E
    Biochem Biophys Res Commun; 1993 Jun; 193(3):1137-44. PubMed ID: 7686745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new cGMP phosphodiesterase isolated from bovine platelets is substrate for cAMP- and cGMP-dependent protein kinases: evidence for a key role in the process of platelet activation.
    Robichon A
    J Cell Biochem; 1991 Oct; 47(2):147-57. PubMed ID: 1661738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin induced phosphorylation and activation of the cGMP-inhibited cAMP phosphodiesterase in human platelets.
    López-Aparicio P; Rascón A; Manganiello VC; Andersson KE; Belfrage P; Degerman E
    Biochem Biophys Res Commun; 1992 Jul; 186(1):517-23. PubMed ID: 1321613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imidazoquinoline derivatives: potent inhibitors of platelet cAMP phosphodiesterase which elevate cAMP levels and activate protein kinase in platelets.
    Seiler S; Gillespie E; Arnold AJ; Brassard CL; Meanwell NA; Fleming JS
    Thromb Res; 1991 Apr; 62(1-2):31-42. PubMed ID: 1649498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P; Prigent AF; Lagarde M; Nemoz G
    Mol Pharmacol; 1993 Nov; 44(5):1027-35. PubMed ID: 8246905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases.
    Manns JM; Brenna KJ; Colman RW; Sheth SB
    Thromb Haemost; 2002 May; 87(5):873-9. PubMed ID: 12038792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Purification and properties of the cGMP-inhibited cAMP phosphodiesterase from bovine aortic smooth muscle.
    Rascón A; Lindgren S; Stavenow L; Belfrage P; Andersson KE; Manganiello VC; Degerman E
    Biochim Biophys Acta; 1992 Mar; 1134(2):149-56. PubMed ID: 1313303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
    Eigenthaler M; Nolte C; Halbrügge M; Walter U
    Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of a human platelet cyclic nucleotide phosphodiesterase.
    Grant PG; Colman RW
    Biochemistry; 1984 Apr; 23(8):1801-7. PubMed ID: 6326810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and activation of cAMP- and cGMP-dependent protein kinases in highly purified human platelet plasma and intracellular membranes.
    el-Daher SS; Eigenthaler M; Walter U; Furuichi T; Miyawaki A; Mikoshiba K; Kakkar VV; Authi KS
    Thromb Haemost; 1996 Dec; 76(6):1063-71. PubMed ID: 8972032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.
    Hidaka H; Asano T
    Biochim Biophys Acta; 1976 Apr; 429(2):485-97. PubMed ID: 177073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.
    Benjamin CW; Lin AH; Morris J; Wishka DG; Gorman RR
    J Pharmacol Exp Ther; 1993 Apr; 265(1):457-62. PubMed ID: 7682615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new nonhydrolyzable reactive cAMP analog, (Sp)-adenosine-3',5'-cyclic-S-(4-bromo-2,3-dioxobutyl)monophosphorothioate irreversibly inactivates human platelet cGMP-inhibited cAMP phosphodiesterase.
    Hung SH; Madhusoodanan KS; Beres JA; Boyd RL; Baldwin JL; Zhang W; Colman RW; Colman RF
    Bioorg Chem; 2002 Feb; 30(1):16-31. PubMed ID: 11955000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity.
    Grant PG; Mannarino AF; Colman RW
    Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9071-5. PubMed ID: 2461561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification, properties and polyclonal antibodies for the particulate, low Km cAMP phosphodiesterase from bovine adipose tissue.
    Degerman E; Manganiello VC; Newman AH; Rice KC; Belfrage P
    Second Messengers Phosphoproteins; 1988; 12(4):171-82. PubMed ID: 2854560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.